Anika Therapeutics (ANIK) EBT Growth (1y) (2011 - 2026)
Anika Therapeutics (ANIK) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 48.64% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -1.94% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -24.84% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 1,578.91% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 262.69% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 45.00% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -342.95% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 62.03% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 248.00% |
| 10 | Anika Therapeutics | 198.70 Mn | 131.91 Mn | 19.00 Mn | -24.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.61% |
| Dec 31, 2025 | 963.61% |
| Sep 30, 2025 | -788.00% |
| Jun 30, 2025 | -226.42% |
| Mar 31, 2025 | -102.25% |
| Dec 31, 2024 | -105.04% |
| Sep 30, 2024 | 104.62% |
| Jun 30, 2024 | 60.42% |
| Mar 31, 2024 | 84.08% |
| Dec 31, 2023 | 99.22% |
| Sep 30, 2023 | -31.28% |
| Jun 30, 2023 | 6.54% |
| Mar 31, 2023 | -224.00% |
| Dec 31, 2022 | 189.83% |
| Sep 30, 2022 | -528.27% |
| Jun 30, 2022 | -135.98% |
| Mar 31, 2022 | -405.19% |
| Dec 31, 2021 | 22.12% |
| Sep 30, 2021 | 115.35% |
| Jun 30, 2021 | 194.08% |